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Abstract.  Histamine receptors are present on the sur- 
face of various normal and tumor-derived cell types, 
where their biological function is incompletely under- 
stood. Here we report that histamine not only stimu- 
lates cell proliferation under serum-free conditions, 
but also is chemotactic for human carcinoma (Hela 
and A431) and melanoma (A875) cells expressing H~ 
type receptors.  Histamine was found to be a potent 
activator of phospholipase C, leading to polyphospho- 
inositide hydrolysis and subsequent intracellular  Ca  2+ 
mobilization.  In addition,  histamine  also causes the 
protein kinase C-mediated activation of Na+/H  + ex- 
change,  as evidenced by an amiloride-sensitive rise in 
cytoplasmic pH. All histamine-induced  responses, in- 
cluding chemotaxis and DNA synthesis, are com- 
pletely inhibited by the H~ receptor antagonist pyril- 
amine,  but not by cimetidine,  an inhibitor of 
histamine  H2 type receptors.  Our results suggest that 
histamine  may have a previously unrecognized role in 
the migration and proliferation of cells expressing H~ 
receptors. 
H 
ISTAMINE is a widely occurring chemical  mediator 
that has long been known as a neurotransmitter,  in- 
flammatory factor, and a modulator of gastro-intes- 
tinal functions (10, 24). It has also been suggested that hista- 
mine is involved in certain types of cell proliferation  in vivo, 
such as wound healing,  embryonic development, and tumor 
growth (for review, see reference  2).  There are several re- 
ports that elevated levels of histamine  and of its synthesizing 
enzyme are associated with rapid tissue growth (17), but the 
precise link, if any, between histamine  and cell proliferation 
remains  obscure. 
Three types of histamine  receptors (H,, H2, and H3) have 
been identified that differ in their  sensitivity  to antagonists 
and mediate different  actions (14).  While activation  of H2 
type receptors leads  to an increase in cAMP (12),  the H~ 
type receptor is linked to phosphoinositide  breakdown and 
Ca  2÷ mobilization  (8, 9, 23) and, therefore,  is an attractive 
candidate  for mediating  growth stimulation. 
Here we report that exogenously added histamine not only 
stimulates  DNA synthesis and cell division but also evokes 
a chemotactic response in human Hela and A431 carcinoma 
cells and A875 melanoma cells. We show that these novel ac- 
tions of histamine are mediated by the H, type receptor that 
triggers the hydrolysis of phosphoinositides with consequent 
formation of various second messengers.  Our results suggest 
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that histamine  may have a novel role in the migration  and 
proliferation  of Ht receptor-bearing (tumor)  cells. 
Materials and Methods 
Materials 
BSA, cimetidine,  DiCS,  histamine, and pyrilamine were purchased from 
Sigma Chemical Co. (St. Louis, MO). Other reagents were from the follow- 
ing sources: Bis(carboxy-ethyl)carboxyfluorescein  (BCECF) l from Molec- 
ular Probes (Eugene, OR) epidermal growth factor (EGF), receptor grade, 
from Collaborative Research, Inc.  (Waltham,  MA); FCS from Hyclone 
Laboratories (Logan,  UT);  Hoechts 33258 from Bochringer Mannheim 
GmbH  (Mannheim,  FRG);  indo-I  acetoxymethylester from  Molecular 
Probes (Eugene,  OR)  and  polycarbonate  filters  from  Nuclepore  Corp. 
(Pleasanton, CA). Myo[2-3H]inositol (12.3 Ci/mmol) and cAMP assay kits 
were obtained from Amersham International (Amersham, UK). 
Cell Culture 
Human A431 and Hela carcinoma and A875 melanoma cells were routinely 
grown at 37°C  in DME containing 7.5%  (vol:vol) FCS at 5% CO2. 
Cell Counting 
Hela, A431, and A875 cells were seeded at a density of 103/cm  2 (Hela and 
A431) or 5 • 102/cm  2 (A875) in DME containing 7.5% (vol:vol) fetal calf 
serum and allowed to attach for 24 h. After shifting the cultures to serum- 
1.  Abbreviations  used in  this paper:  BCECF,  bis(carboxy-ethyl)carboxy- 
fluorescein;  EGF,  epidermal  growth  factor;  IMBX,  isobutylmethylxan- 
thine. 
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transferrin, growth factors were added.  24-48  h  later cells were resus- 
pended and counted. Generation time (cell doubling time) was calculated 
from cell counts after 24 and 48 h of stimulation. 
DNA Content 
Cells were seeded and allowed to attach in DME. 24 h before growth factor 
addition, the cultures  were shifted to  serum-free medium consisting of 
DME/Ham's F-12 (1:1, vol:vol), supplemented with 10/zg/ml transferrin. 
After 2 d of  hormonal stimulation, a cell lysate was prepared and total DNA 
content was measured using the nuclear dye Hoechst 33258 (18). 
Determination of  lnositol Phosphates 
Nearly confluent cultures were shifted to serum-free DME/Ham's F-12 me- 
dium, containing 10/zg/ml transferrin and 2/~Ci [3H]inositol  for 24 h. Af- 
ter stimulation, an inositoi phosphate containing fraction was prepared and 
quantitated by anion exchange chromatography as described previously 
(27). HPLC elution profiles were obtained by analyzing inositol phosphates 
containing fractions on a  Partisil Sax column, eluted with a gradient to 
1.5 M  ammonium  formate/phosphoric acid  (pH,  3.7).  [3H]radioactivity 
was determined by on-line scintillation counting using a radioactivity moni- 
tor (Berthold LB506C;  Betrow,  Rotterdam, the Netherlands). 
cAMP Measurements 
Nearly confluent cells in 6-well tissue culture dishes were preincubated for 
2 h  in serum-free DME containing 20 mM Hepes (pH, 7.6).  Thereafter, 
cells were exposed to 1 mM isobutylmethylxanthine (IMBX), and, 10 min 
later, were stimulated with agonist. The reactions were stopped by adding 
10% (wt/vol) ice-cold  TCA. After centrifugation, the supernatants were ex- 
tracted with diethylether to remove TCA and neutralized with Tris-base. 
Cellular content of cAMP was determined using the [3H]cAMP assay kit 
from Amersham International according to the instructions of  the manufac- 
turer. 
Ionic Responses 
Nearly confluent cultures, attached to glass coverslips and maintained in 
serum-free DME/Ham's F-12 (1:1, vol:vol) medium containing 10/zg/ml 
transferrin for 24 h, were loaded with the fluorescent indicators indo-1 (for 
Ca  2+) or BCECF (for phi). Fluorescence was recorded and calibrated as 
described p~viously (21). 
Chemotactic Assay 
Chemotactic assays were carried out in modified Boyden chambers (11), 
equipped with gelatin-coated filters from Nuclepore Corp. (8 #m pore size). 
Cells, resuspended to a density of 106 cells/ml, were seeded into the upper 
chamber, while a histamine-containing agar solution (5%) was put in the 
lower chamber. All incubations were performed in DME/Ham's F-12 (1:1, 
vol:vol) medium containing 10/~g/ml transferrin and 1 mg/ml BSA. The 
results are expressed as number of cells migrated through the membrane 
per microscopic field (400×) during a  12-h period. 
Results 
Mitogenesis 
In an initial screening, we found Ca2+-mobilizing H, recep- 
tors to be present on various human tumor cell lines, includ- 
ing Hela, A431, epidermoid carcinoma, HT-29, colon carci- 
noma, and A875,  melanoma cells, but not on MCF-7 breast 
carcinoma cells. No functional Hj receptors were found on 
mouse NIH and Swiss 3T3 cells or on rat-1  fibroblasts. The 
Hela carcinoma cell line constitutes a convenient model for 
studying potential effects of histamine on cell proliferation, 
since these cells can be grown under serum-free conditions 
while they remain growth factor-responsive (15). When kept 
in a serum-free medium containing transferrin, Hela cells re- 
main viable with a mean population doubling time of 72 h. 
Table L Growth Stimulation  of  Human Carcinoma 
and Melanoma Cells by Histamine 
Cell density after  Mean generation 
48 h (cells x  10-2/cm  2)  time (h) 
Hela  A431  A875  Hela  A431  A875 
Control  16  +  1  19  +  1  10+  1  72  50  56 
Histamine (100  /~M)  26  +  2  30  +2  16+  1  31  29  36 
Insulin (5/~g/ml)  26  +  2  28  +  1  16  +  1  31  30  36 
EGF (50 ng/ml)  51  :l: 2  ND  11  +  1  19  ND  48 
Cells were seeded and allowed to attach for 24 h before growth stimulation. 
24-48 h after addition of the various growth factors, cells were resuspended 
and counted.  Data are expressed as means ±  SEM for triplicate  experiments. 
Addition of histamine to such serum-free cultures was found 
to  stimulate  DNA  synthesis  and  cell  division  in  a  dose- 
dependent manner,  half-maximal effects being observed at 
10-15  #M  and  a  saturating  response  at  5  x  10  -5  M.  As 
shown in Table I and Fig.  1 histamine is somewhat less po- 
tent as EGF in stimulating Hela cell growth, with histamine 
(10 -4 M)  decreasing  generation time from 72  to 31  h and 
EGF (50 ng/ml) to 19 h. Insulin (5/~g/ml) was equally potent 
as histamine (Table I), whereas mitogenic peptides such as 
bombesin,  bradykinin,  and  substance  P,  had no effect on 
Hela cell proliferation  (our unpublished  observations).  When 
added  together,  histamine  and  insulin  evoke  an  additive 
rather than a synergistic proliferative response (not shown). 
The mitogenic activity of histamine is not restricted to Hela 
cells. Also in A431 cells and A875 melanoma cells histamine 
exerts  a marked mitogenic effect (Table  I). 
The growth stimulatory action of histamine appears to be 
mediated by the H,  type receptor,  since the H~ antagonist 
pyrilamine completely blocks histamine-induced DNA syn- 
thesis, whereas the H2 antagonist cimetidine, even at milli- 
molar concentrations, has no detectable effect (Fig.  1). Im- 
portantly,  these antagonists affect neither the basal rate nor 
the EGF- and/or insulin-stimulated  rate of DNA  synthesis 
(Fig.  1). 
Involvement of  Phospholipase C 
As illustrated  in Fig. 2, addition of histamine to Hela cells 
evokes  the phospholipase  C-mediated  breakdown of poly- 
phosphoinositides which results in rapid formation of inositol 
Figure 1. Effects of histamine, EGF and histamine receptor antago- 
nists on cellular DNA content in Hela cells. Concentrations used: 
histamine, 100/~M; EGF, 50 ng/ml; pyrilamine, 1/zM; cimetidine, 
1 raM.  Values are given as means  +  SEM for triplicate cultures. 
Qualitatively  similar results were obtained with A4311  and A875 
ceils. 
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evoked by histamine  in  Hela  cells.  A,  time 
course of  histamine-induced inositol phosphate 
accumulation  in  Li+-treated cultures. [3H]- 
Inositol  prelabeled  cultures  were  incubated 
with  histamine  (100 #M)  for the  indicated 
times in the presence of 10 mM LiCI. Thereaf- 
ter, an inositol phosphate containing fraction 
was prepared and analyzed as described under 
Materials and Methods. Inset shows the effects 
of pyrilamine (1 ~M, hatched bars and cimeti- 
dine;  1 raM,  dotted bars) on the histamine- 
induced inositol phosphate production (30-min 
incubations). Data are expressed as means ± 
SEM for triplicate incubations. B, HPLC pro- 
files of [3H]inositol phosphates obtained from 
control and histamine-stimulated cultures (100 
#M during  10 s). 
phosphates (Fig. 2 A). Half maximal stimulation of inositol 
phosphate formation is observed at approx.  1-2 #M hista- 
mine, while the response saturates at  10 #M (Tilly, B. C., 
L. G. J.  Tertoolen, A. C. Lambrechts, R. Remorie, S.  W. 
de Laat, and W. H. Moolenaar, submitted for publication), 
which is in the same range of histamine-induced cell prolif- 
eration.  Like the  stimulation  of DNA  synthesis,  inositol 
phosphate formation is inhibited by pyrilamine (ICs0 "~15 
nM at 100 #M histamine) but not by cimetidine (Fig. 2 A, 
inset), indicating the involvement of H, receptors. EGF and 
insulin had little or no effect on inositol phosphate levels in 
Hela cells (not shown), although other cell types, including 
A431 cells, do show an inositol phosphate response to EGF 
(13,  16, 28). 
Analysis of the various inositol phosphates formed (Fig. 
2 B), reveals a rapid,  several-fold increase in Ins(1,4,5)P3, 
the second messenger for Ca  2+ mobilization (5), and other 
inositol polyphosphates. In addition to generating inositol 
phosphates, histamine transiently stimulates the formation 
of diacylglycerol in [2-3H]glycerol-labeled cells, as revealed 
by using conventional TLC (Till)', B. C., L. G. J. Tertoolen, 
A. C. Lambrechts, R. Remorie, S. W. de Laat, and W.  H. 
Moolenaar,  manuscript  submitted  for publication),  which 
binds to and directly activates protein kinase C. 
Ionic Responses 
The activation of phospholipase C by histamine is expected 
to lead to increases in cytoplasmic free Ca  e+ ([Ca~*]i) and 
pH (pHi), because of Ins(1,4,5)Prmediated Ca  2+ release (5) 
and protein kinase C-activated Na+/H  + exchange (20), re- 
spectively. Fig. 3 shows typical ionic responses to histamine. 
Histamine  elicits  a  rapid,  but  transient,  biphasic  rise  in 
[Ca2+],, which approaches micromolar Ca  ~÷ levels at 10-20 s 
after hormone addition and which is completely blocked by 
pyrilamine  (Fig.  3  A).  The  initial  rise  in  [Ca2+]i rise  is 
largely,  if not entirely, because of release of intracellular 
stored  Ca  2+,  while the  second phase  requires Ca  2+  influx 
across the plasma membrane (Tilly, B. C., L. G. J. Tertoo- 
len,  A.  C.  Lambrechts,  R.  Remorie,  S.  W.  de Laat,  and 
W.  H. Moolenaar, manuscript in preparation). 
Histamine also causes the protein kinase C-mediated acti- 
vation of Na+/H  + exchange, as  shown by a  rise in phi of 
"~0.20 U,  that is abolished in the presence of the Na+/H  + 
exchange inhibitor amiloride (0.5  mM),  while subsequent 
addition of cell permeable diacylglycerol (diCS) does not 
cause  an  additional  elevation of pHi  (Fig.  3  B).  Similar 
ionic responses to histamine were observed in  A431  and 
A875  cells. 
Independence of  Adenylate Cyclase 
Although  the  mitogenic  effects  of  Ca  2+  mobilizing  hor- 
mones are thought to proceed via the phospholipase C signal 
transduction pathway,  recent evidence suggests that inhibi- 
tion of adenylate cyclase (through a receptor-linked inhibi- 
tory G  protein;  G~)  is  actually more important for mito- 
genesis  (26).  We  determined the  effects of histamine  on 
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Figure 3.  Histamine-induced  ionic 
responses in Hela cells. A, increase 
in [Ca2+]i after addition of histamine 
(100 #M) in the absence and presence 
of pyrilamine (1 #M), as indicated. 
B, rise in cytoplasmic pH (pHi) in- 
duced  by histamine; no further in- 
crease is observed after subsequent 
addition of  dioctanoyl  (diC8, 50 #M). 
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Figure 4.  Induction of a che- 
motactic  response  by histamine 
in Hela cells and inhibition by 
pyrilamine (250 nM). Chemo- 
tactic assays were performed 
as described under Materials 
and Methods. The  indicated 
histamine concentration  repre- 
sents the  final concentration 
after complete equilibration of 
both upper and lower  chamber. 
Data are expressed  as the num- 
ber of cells +  SEM (n  =  3) 
migration through the  mem- 
brane  per  microscopic field 
(400x). 
intracellular levels of adenosine 3',5'-monophosphate  (cAMP) 
following stimulation of adenylate cyclase by isoproterenol 
(10/~M); the phosphodiesterase inhibitor IMBX (0.5 mM) 
was included to ensure that changes in cAMP levels were not 
mediated by  phosphodiesterase action.  Under  conditions 
where exogenous phosphatidic acid (cf. reference 22) inhib- 
its cAMP accumulation up to 60% within 15 min (from 1.23 
to 0.30  +  0.04 pmol cAMP/106 cells), histamine completely 
failed to attenuate isoproterenol-induced cAMP accumula- 
tion in Hela cells. Thus, mitogenic signaling through the H~ 
type receptor does not appear to involve the G~ protein that 
inhibits adenylate cyclase. 
Chemotaxis 
Several agents, including certain growth regulators, promote 
the chemotactic migration of their target cells (4, 25, 29). 
This activity is important in wound healing, but chemotaxis 
may also be involved in tumor cell metastasis (19). We exam- 
ined whether histamine can function as a chemoattractant 
for Hela cells using the modified Boyden chamber assay (11), 
in which cells are allowed to migrate through membrane fil- 
ters. Fig. 4 shows that histamine evokes a potent chemotactic 
response in a dose-dependent manner, with a half-maximal 
effect at "~5  x  10  -6 M.  Histamine-induced chemotaxis is 
completely blocked by pyrilamine (Fig. 4), indicating again 
the involvement of Ha receptors.  A  chemotactic response 
(an approximately twofold increase relative to the control) is 
also observed after stimulating A875 melanoma cells with 
histamine (100  #M),  although the  chemotaxis assay was 
technically more difficult than with Hela cells because of the 
tendency of melanoma cells to aggregate when resuspended 
in a Boyden chamber. 
Discussion 
The present data clearly demonstrate that histamine, a ubiq- 
uitously occurring local hormone, can function as a growth 
factor and chemoattractant for cells types that express the 
Ca2÷-mobilizing  H~  type receptor.  We found no evidence 
that mitogenic signaling through H, type receptors may in- 
volve alterations in cAMP levels.  Our results raise the in- 
triguing possibility of a role for histamine in promoting cell 
growth and migration in vivo. The present findings also sug- 
gest that histamine-secreting mast cells may have a more im- 
portant role in modulating cell proliferation than has been 
assured to date. Indeed, the finding that mast cells are fre- 
quently abundant in the contiguous tissue of metastatic tu- 
mors supports this possibility (7). 
Interestingly, histamine is not only stored in mast cells but 
is also actively synthesized in various other cell types. In par- 
ticular, high levels of histamine and its synthesizing enzyme 
occur in many tissues undergoing rapid cell growth or tissue 
repair,  including regenerating liver, bone marrow, embry- 
onic tissues,  and experimental tumors (1,  10,  17,  6).  Al- 
though it remains to be seen whether histamine produced by 
these cells is released into the extracellular space, it is tempt- 
ing to speculate that newly synthesized histamine, acting via 
H~ receptors, may contribute to cell proliferation and de- 
velopment by serving as an autocrine growth and motility 
factor. 
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